Paper26410367
The role of inflammatory biomarkers in developing targeted cardiovascular therapies: lessons from the cardiovascular inflammation reduction trials.
Passacquale G and 2 others. Cardiovasc Res, 2016. Cited by 37 papers, by iCite.
Cite this record
ConductScience Library. The role of inflammatory biomarkers in developing targeted cardiovascular therapies: lessons from the cardiovascular inflammation reduction trials. Papers, record 26410367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26410367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The role of inflammatory biomarkers in developing targeted cardiovascular therapies: lessons from the cardiovascular inflammation reduction trials.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Inflammatory Agents | Major topic |
| C-Reactive Protein | Major topic |
| Cardiovascular Diseases | Major topic |
| Monocytes | Major topic |
| Atherosclerosis | |
| Biomarkers | |
| Chemokine CCL5 | |
| Humans | |
| Lipoproteins, LDL | |
| Phospholipase A2 Inhibitors | |
| Prognosis | |
| Receptors, IgG | |
| Tumor Necrosis Factor-alpha |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| FS/13/45/30345 | British Heart Foundation | United Kingdom | PubMed |
Source PubMed
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41560044 | Dissecting the relationship between hypertensive disorders of pregnancy and branched-chain amino acids: An integrated investigation combining Mendelian randomization, transcriptomics, and machine learning. | Medicine (Baltimore) | 2026 | https://conductscience.org/library/papers/41560044 | PubMed |
| 41225126 | Dental Pulp-Derived Stem Cells in Mitigating Inflammatory Arthritis and Their Mechanisms in Conjunction with Oral Diseases. | Adv Exp Med Biol | 2026 | https://conductscience.org/library/papers/41225126 | PubMed |
| 39528733 | Association of tricarboxylic acid cycle related-metabolites with hypertension in older adults: a community-based cross-sectional study. | J Hum Hypertens | 2025 | https://conductscience.org/library/papers/39528733 | PubMed |
| 38983558 | Diabetes mellitus associated neurovascular lesions in the retina and brain: A review. | Front Ophthalmol (Lausanne) | 2022 | https://conductscience.org/library/papers/38983558 | PubMed |
| 38469117 | Connecting epigenetics and inflammation in vascular senescence: state of the art, biomarkers and senotherapeutics. | Front Genet | 2024 | https://conductscience.org/library/papers/38469117 | PubMed |
| 38420789 | Causal Relationship Between Branched-Chain Amino Acids and Hypertension: A Mendelian Randomization Study. | J Am Heart Assoc | 2024 | https://conductscience.org/library/papers/38420789 | PubMed |
| 37908502 | High residual cardiovascular risk after lipid-lowering: prime time for Predictive, Preventive, Personalized, Participatory, and Psycho-cognitive medicine. | Front Cardiovasc Med | 2023 | https://conductscience.org/library/papers/37908502 | PubMed |
| 35842184 | Perivascular adipose tissue in autoimmune rheumatic diseases. | Pharmacol Res | 2022 | https://conductscience.org/library/papers/35842184 | PubMed |
| 34970157 | Pathophysiology of Circulating Biomarkers and Relationship With Vascular Aging: A Review of the Literature From VascAgeNet Group on Circulating Biomarkers, European Cooperation in Science and Technology Action 18216. | Front Physiol | 2021 | https://conductscience.org/library/papers/34970157 | PubMed |
| 33003303 | Association of Major Histocompatibility Complex Class I Related Chain A/B Positive Microparticles with Acute Myocardial Infarction and Disease Severity. | Diagnostics (Basel) | 2020 | https://conductscience.org/library/papers/33003303 | PubMed |
| 30952610 | State-of-the-art review article. Atherosclerosis affecting fat: What can we learn by imaging perivascular adipose tissue? | J Cardiovasc Comput Tomogr | 2019 | https://conductscience.org/library/papers/30952610 | PubMed |
| 30181568 | Microvascular dysfunction in ankylosing spondylitis is associated with disease activity and is improved by anti-TNF treatment. | Sci Rep | 2018 | https://conductscience.org/library/papers/30181568 | PubMed |
| 29459239 | Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms. | Can J Cardiol | 2018 | https://conductscience.org/library/papers/29459239 | PubMed |
| 28972117 | Nile Red Quantifier: a novel and quantitative tool to study lipid accumulation in patient-derived circulating monocytes using confocal microscopy. | J Lipid Res | 2017 | https://conductscience.org/library/papers/28972117 | PubMed |
| 28838042 | The role of infiltrating immune cells in dysfunctional adipose tissue. | Cardiovasc Res | 2017 | https://conductscience.org/library/papers/28838042 | PubMed |
| 28525917 | Heterogenous treatment effects: secrets for a reliable treat-to-target trial? | Cardiovasc Res | 2017 | https://conductscience.org/library/papers/28525917 | PubMed |
| 28446965 | Role of circulating factors in cardiac aging. | J Thorac Dis | 2017 | https://conductscience.org/library/papers/28446965 | PubMed |
| 28066424 | Stimulation of PBMC and Monocyte-Derived Macrophages via Toll-Like Receptor Activates Innate Immune Pathways in HIV-Infected Patients on Virally Suppressive Combination Antiretroviral Therapy. | Front Immunol | 2016 | https://conductscience.org/library/papers/28066424 | PubMed |
| 27798770 | Impact of a Proprietary Standardized Olive Fruit Extract (SOFE) on Cardio-Ankle Vascular Index, Visual Analog Scale and C-Reactive Protein Assessments in Subjects with Arterial Stiffness Risk. | Drugs R D | 2016 | https://conductscience.org/library/papers/27798770 | PubMed |
| 26861255 | Effect of monoclonal antibodies to PCSK9 on high-sensitivity C-reactive protein levels: a meta-analysis of 16 randomized controlled treatment arms. | Br J Clin Pharmacol | 2016 | https://conductscience.org/library/papers/26861255 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26410367
GET https://conductscience.org/api/papers/v1/26410367/authors